Kidney cancer, Renal cell cancer
Results
Phase 1
This trial looked at the combination of everolimus and dovitinib for a type of kidney cancer (renal cell cancer) called clear cell cancer that has spread.
Recruitment start: 1 May 2011
Recruitment end: 10 October 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Prof Thomas Powles
Experimental Cancer Medicine Centre (ECMC)
Novartis
Queen Mary University of London
Last reviewed: 18 June 2017
CRUK internal database number: 8197
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
